Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. California Pharmacy & Compounding Center
WARNING LETTER
•California Pharmacy & Compounding Center•October 17, 2014

California Pharmacy & Compounding Center – FDA Warning Letter, Oct 17, 2014

Record Details

On June 17, 2015, the FDA issued a Warning Letter to California Pharmacy & Compounding Center (CPCC) following inspections from August 18-25, 2014, and October 14-17, 2014. CPCC, registered as an outsourcing facility under FDCA section 503B, was cited for serious deficiencies in sterile drug production, rendering products adulterated and misbranded.

Key violations include: - **Insanitary Conditions (501(a)(2)(A) FDCA):** Failure to monitor pressure differential between cleanroom and anteroom, and absence of environmental monitoring during sterile production periods (Jan-June 2014), posing contamination risk. - **CGMP Violations (501(a)(2)(B) FDCA):** Lack of written procedures for preventing microbiological contamination and validating aseptic processes (21 CFR 211.113(b)); inadequate personnel gowning (21 CFR 211.28(a)); insufficient environmental monitoring system (21 CFR 211.42(c)(10)(iv)); failure to investigate discrepancies (21 CFR 211.192); and inadequate equipment maintenance for aseptic conditions (21 CFR 211.42(c)(10)(vi)). - **Failure to Meet 5

Company
California Pharmacy & Compounding Center
Inspection date
October 17, 2014
Product type
Drugs
Office
Los Angeles District Office
People
  • Alonza E. Cruse (Director)
  • William S. Vitale (Compliance Officer)
  • Virginia Herold ( Executive Officer)
  • David Mazzera (Chief. Environmental Program Manager I)
View Company Profile

ID · 565ef235-df5b-4460-a90a-04c9ccb32421

Violation Codes10
21 U.S.C. 353b21.U.S.C. 355(a)21 U.S.C. 352(f)(l)21 U.S.C. 360eee-121 U.S.C. 351(a)(2)(A)21 U.S.C. 331(k)21 U.S.C. 331(d)21 CFR 211.113(b)21 CFR 211.28(a)21 CFR 211.42(c)(10)(iv)

Full citation text and observation details available on the Dashboard.

Other documents for California Pharmacy & Compounding Center
  • 483 - 2018-12-17December 17, 2018
  • AMENDED_483 - 2018-12-07December 7, 2018
  • 483 - 2017-04-21April 21, 2017
  • 483 - 2016-08-31August 31, 2016
  • 483 - 2014-10-17October 17, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore California Pharmacy & Compounding Center
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.